Engineers Gate Manager LP Syros Pharmaceuticals, Inc. Transaction History

Engineers Gate Manager LP

  • $4.27 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$4.08 - $5.66 $335,376 - $465,252
-82,200 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$5.01 - $7.48 $411,822 - $614,856
82,200 New
82,200 $448,000
Q4 2020

Feb 16, 2021
SELL
$6.66 - $14.66 $119,114 - $262,194
-17,885 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$8.69 - $14.47 $155,420 - $258,795
17,885 New
17,885 $158,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email